Elsevier Appoints Dr. Peter Edelstein as Chief Medical Officer

June 25, 2014

PHILADELPHIA, June 25, 2014 /PRNewswire/ –

Veteran cancer surgeon, author and patient empowerment advocate joins

Elsevier Clinical Solutions management team

Elsevier [http://www.elsevier.com ], a world-leading provider of scientific, technical
and medical information products and services, announced today that Peter Edelstein, MD,
has joined the company as Chief Medical Officer.

“Dr. Edelstein brings deep clinical and business experience to our team at Elsevier,”
said Jay Katzen, President, Elsevier Clinical Solutions. “We will look for him to help us
improve the way we engage with hospitals, health systems and other healthcare providers as
they seek best-of-suite solutions to meet their workflow and evidence-based practice

Edelstein is board certified by the American College of Surgeons and the American
Society of Colon and Rectal Surgery. He has more than 35 years of experience practicing
medicine and in healthcare administration. Edelstein was in private practice for several
years before serving on the surgical faculty at Stanford University, where he focused on
gastrointestinal, oncologic and trauma surgery. He then spent more than a decade as an
executive in the Silicon Valley medical device industry. Edelstein’s most recent role was
as Chief Medical Officer for the healthcare business at LexisNexis Risk Solutions, a Reed
Elsevier company. He is also the author of the recently published book, ‘Own Your Cancer:
A Take-Charge Guide for the Recently Diagnosed & Those Who Love Them’.

“Elsevier’s reputation is well known and highly valued by care providers across the
world, and the company is recognized by clinicians everywhere as a premier medical
information provider,” Edelstein said. “I look forward to working with our talented and
knowledgeable teams and full range of clinical solutions as we tell the story of today’s
Elsevier. By applying my clinical and business experiences and perspectives, I hope to
help Elsevier continue to grow and offer the best integrated solutions to our customers.”

Edelstein will serve as Elsevier’s clinical expert engaging with strategic partners,
clients, and professional societies. With a focus on content-driven electronic provider
solutions and patient education and empowerment products, he will be actively engaged with
executive leadership and field teams in strategy and business development, product,
marketing, and sales. Edelstein joins the Elsevier Clinical Solutions management team,
which includes Chief Medical Informatics Officer Jonathan Teich, MD, and Chief
Professional Practice Officer Michelle Troseth, RN, MSN, DPNAP, FAAN.

For more information, visit http://www.elsevier.com/about/experts.

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the
performance of science, health, and technology professionals, empowering them to make
better decisions, deliver better care, and sometimes make groundbreaking discoveries that
advance the boundaries of knowledge and human progress. Elsevier provides web-based,
digital solutions – among them ScienceDirect [http://www.sciencedirect.com ], Scopus
[http://www.scopus.com ], Elsevier Research Intelligence
[http://www.elsevier.com/online-tools/research-intelligence ] and ClinicalKey
[https://www.clinicalkey.com ] – and publishes nearly 2,200 journals, including The Lancet
[http://www.thelancet.com ] and Cell [http://www.cell.com ], and over 25,000 book titles,
including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC [http://www.reedelsevier.com ], a
world-leading provider of professional information solutions in the Science, Medical,
Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed
Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange),
RUK and ENL (New York Stock Exchange).

        Media contact
        Christopher Capot
        Director, Corporate Relations

SOURCE Elsevier

Source: PR Newswire

comments powered by Disqus